September 26, 2025

Hold on, drug lovers! President Donald Trump just slapped a shocking 100% tariff on some pharmaceutical products. Sounds like a massive blow, right? But wait, Indian drugmakers might not get the full punch of this big trade hammer. Why? First off, these tariffs apply to finished drug formulations, not the raw materials that Indian companies mostly export. So the backbone of India's pharma exports still stays strong. Plus, Indian firms cleverly export many drugs through third countries, bypassing direct US entry with tariffs. Also, the US depends heavily on India for affordable medicines, which keeps things flexible. Experts say, “While the headlines are scary, Indian companies have room to maneuver.” So, this tariff story is not just black and white — it spiced with trade tricks and smart strategies. How will this play out in the long run? Indian drugmakers are ready to hustle and show resilience in the face of Trump’s tariff storm!

Read More at News →

Tags: Donald trump, Pharma tariffs, Indian drugmakers, Us trade policy, Pharmaceutical exports,